There are separate drug profiles for each of the single antiretrovirals (ARVs), fixed-dose combinations (FDCs) and co-packs containing two or three ARVs. Each drug profile contains the following sections:

General

The most salient issues related to access to each product is summarised here. The focus is on the availability of products, their affordability and their adaptability for the developing world.

A special comment has been included when appropriate with regard to paediatrics.